MENU
  • About Us
  • Profile
  • Blog
    • Comment Policy
  • Category
    • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Empowering Life Sciences for Blooming Life
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
  • Profile
  • Blog
    • Comment Policy
  • Category
    • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  • About Us
  • Profile
  • Blog
  • Category
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
  • Profile
  • Blog
    • Comment Policy
  • Category
    • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  1. Home
  2. FDA Approval

FDA Approval– tag –

  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Fam-trastuzumab deruxtecan-nxki (Enhertu) Approved by FDA for HER2-Low and Ultralow Breast Cancer

    【FDA Approval Alert】Daiichi Sankyo's Enhertu Approved for HER2-Low and Ultralow Breast Cancer (January 27, 2025) On January 27, 2025, the U.S. FDA approved fam-trastuzumab deruxtecan-nxki (Enhertu) for adults with unresectable or metas...
    2025-01-29
  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Datopotamab Deruxtecan-dlnk (Datroway) Approved by FDA for HR-Positive, HER2-Negative Breast Cancer

    【FDA Approval Alert】Daiichi Sankyo's Datroway Approved for HR-Positive, HER2-Negative Breast Cancer (January 17, 2025) On January 17, 2025, the U.S. FDA approved datopotamab deruxtecan-dlnk (Datroway) for adults with unresectable or me...
    2025-01-18
12
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English